AMGN
Price
$317.17
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
BIIB
Price
$185.01
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
Ad is loading...

AMGN vs BIIB

Header iconAMGN vs BIIB Comparison
Open Charts AMGN vs BIIBBanner chart's image
Amgen
Price$317.17
Change-$0.00 (-0.00%)
Volume$1.82M
CapitalizationN/A
Biogen
Price$185.01
Change-$0.00 (-0.00%)
Volume$1.89M
CapitalizationN/A
View a ticker or compare two or three
AMGN vs BIIB Comparison Chart
Loading...
AMGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AMGN vs. BIIB commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Buy and BIIB is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (AMGN: $317.17 vs. BIIB: $185.01)
Brand notoriety: AMGN and BIIB are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 98% vs. BIIB: 159%
Market capitalization -- AMGN: $151.69B vs. BIIB: $31.34B
AMGN [@Pharmaceuticals: Major] is valued at $151.69B. BIIB’s [@Pharmaceuticals: Major] market capitalization is $31.34B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 4 FA rating(s) are green whileBIIB’s FA Score has 1 green FA rating(s).

  • AMGN’s FA Score: 4 green, 1 red.
  • BIIB’s FA Score: 1 green, 4 red.
According to our system of comparison, AMGN is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 4 TA indicator(s) are bullish while BIIB’s TA Score has 5 bullish TA indicator(s).

  • AMGN’s TA Score: 4 bullish, 5 bearish.
  • BIIB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BIIB is a better buy in the short-term than AMGN.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а +0.14% price change this week, while BIIB (@Pharmaceuticals: Major) price change was +0.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.02%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +8.84%.

Reported Earning Dates

AMGN is expected to report earnings on Feb 04, 2025.

BIIB is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.02% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMGN($152B) has a higher market cap than BIIB($31.3B). BIIB has higher P/E ratio than AMGN: BIIB (26.95) vs AMGN (22.66). AMGN YTD gains are higher at: 12.548 vs. BIIB (-28.504). AMGN has higher annual earnings (EBITDA): 14.8B vs. BIIB (2.04B). AMGN has more cash in the bank: 10.9B vs. BIIB (1.05B). BIIB has less debt than AMGN: BIIB (7.34B) vs AMGN (64.6B). AMGN has higher revenues than BIIB: AMGN (28.2B) vs BIIB (9.84B).
AMGNBIIBAMGN / BIIB
Capitalization152B31.3B486%
EBITDA14.8B2.04B726%
Gain YTD12.548-28.504-44%
P/E Ratio22.6626.9584%
Revenue28.2B9.84B287%
Total Cash10.9B1.05B1,038%
Total Debt64.6B7.34B880%
FUNDAMENTALS RATINGS
AMGN vs BIIB: Fundamental Ratings
AMGN
BIIB
OUTLOOK RATING
1..100
674
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
96
Overvalued
PROFIT vs RISK RATING
1..100
11100
SMR RATING
1..100
2177
PRICE GROWTH RATING
1..100
5063
P/E GROWTH RATING
1..100
718
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMGN's Valuation (24) in the Biotechnology industry is significantly better than the same rating for BIIB (96). This means that AMGN’s stock grew significantly faster than BIIB’s over the last 12 months.

AMGN's Profit vs Risk Rating (11) in the Biotechnology industry is significantly better than the same rating for BIIB (100). This means that AMGN’s stock grew significantly faster than BIIB’s over the last 12 months.

AMGN's SMR Rating (21) in the Biotechnology industry is somewhat better than the same rating for BIIB (77). This means that AMGN’s stock grew somewhat faster than BIIB’s over the last 12 months.

AMGN's Price Growth Rating (50) in the Biotechnology industry is in the same range as BIIB (63). This means that AMGN’s stock grew similarly to BIIB’s over the last 12 months.

AMGN's P/E Growth Rating (7) in the Biotechnology industry is in the same range as BIIB (18). This means that AMGN’s stock grew similarly to BIIB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNBIIB
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 12 days ago
53%
Declines
ODDS (%)
Bearish Trend 13 days ago
52%
Bearish Trend 14 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
56%
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
62%
View a ticker or compare two or three
Ad is loading...
AMGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with ABBV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then ABBV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+0.06%
ABBV - AMGN
36%
Loosely correlated
+0.97%
BIIB - AMGN
33%
Loosely correlated
+1.83%
JNJ - AMGN
31%
Poorly correlated
+0.45%
GILD - AMGN
28%
Poorly correlated
-0.27%
NVS - AMGN
27%
Poorly correlated
+1.62%
More

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
+1.83%
AMGN - BIIB
42%
Loosely correlated
+0.06%
OGN - BIIB
36%
Loosely correlated
+1.75%
GILD - BIIB
32%
Poorly correlated
-0.27%
AZN - BIIB
32%
Poorly correlated
+1.25%
NVS - BIIB
29%
Poorly correlated
+1.62%
More